AIMEE KNOTT: Open Payments
NPI 1801554639 · JEFFERSONVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,475 in 78 payments from 17 companies in 2025. Trend: 2023 $1,011 · 2024 $1,805 · 2025 $1,475
Food & beverage: $1,391Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $350 |
| Phathom Pharmaceuticals, Inc. | 24 | $263 |
| Janssen Biotech, Inc. | 5 | $202 |
| GENZYME CORPORATION | 5 | $102 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $83 |
| Janssen Scientific Affairs, LLC | 1 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $73 |
| Regeneron Healthcare Solutions, Inc. | 3 | $70 |
| NeurAxis, Inc. | 1 | $48 |
| PFIZER INC. | 2 | $34 |
Products named: VOQUEZNA, TREMFYA, RINVOQ, DUPIXENT, XIFAXAN, LINZESS, CREON, ENTYVIO.
Industry payments across IN — which companies pay providers there.
